Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of Shortened (4-Infusion) Versus Standard (8-Infusion) Teprotumumab Regimens in Patients With Thyroid Eye Disease (TED) Exhibiting an Early Optimal Clinical Response

NCT07308964 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT07308964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07308964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of Shortened (4-Infusion) Versus Standard (8-Infusion) Teprotumumab Regimens in Patients With Thyroid Eye Disease (TED) Exhibiting an Early Optimal Clinical Response
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
May 31, 2028
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid eye disease, thyroid eye disease (ted), thyroid eye disease, ted